Free Trial
OTCMKTS:GBCS

Selectis Health (GBCS) Stock Price, News & Analysis

Selectis Health logo
$2.00 -0.25 (-11.11%)
As of 05/2/2025 03:42 PM Eastern

About Selectis Health Stock (OTCMKTS:GBCS)

Key Stats

Today's Range
$2.00
$2.00
50-Day Range
$2.00
$2.25
52-Week Range
$1.12
$2.50
Volume
210 shs
Average Volume
2,658 shs
Market Capitalization
$6.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

Receive GBCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter.

GBCS Stock News Headlines

Selectis Health Delays Yearly Report Filing
Selectis Health Makes Key Leadership Announcement
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.
Best Electric Wheelchairs Of 2024
Best Hearing Aids Of 2024
See More Headlines

GBCS Stock Analysis - Frequently Asked Questions

Selectis Health's stock was trading at $1.12 at the beginning of the year. Since then, GBCS shares have increased by 78.6% and is now trading at $2.00.
View the best growth stocks for 2025 here
.

Selectis Health, Inc. (OTCMKTS:GBCS) released its quarterly earnings data on Tuesday, April, 15th. The company reported ($0.19) earnings per share for the quarter. The business earned $10.40 million during the quarter.

Selectis Health shares reverse split before market open on Wednesday, September 22nd 2021. The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT) and Blackstone (BX).

Company Calendar

Last Earnings
4/15/2025
Today
5/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Real estate investment trusts
Sub-Industry
Trading
Current Symbol
OTCMKTS:GBCS
Employees
500
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,970,000.00
Pretax Margin
-14.31%

Debt

Sales & Book Value

Annual Sales
$36.78 million
Price / Cash Flow
N/A
Book Value
($1.22) per share
Price / Book
-1.64

Miscellaneous

Free Float
2,601,000
Market Cap
$6.13 million
Optionable
Not Optionable
Beta
-0.27
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:GBCS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners